Schraga Schwartz

Scientific Advisor at Gotham Therapeutics

Dr. Schraga Schwartz is currently group leader at the Department of Molecular Genetics at the Weizmann Institute of Science. His lab focuses on deciphering the roles played by post-transcriptional modifications on RNA. By combining molecular approaches with tailored computational analyses, Dr. Schwartz’s lab has pioneered methodologies allowing the systematic mapping and quantification of diverse RNA modifications and is currently focusing on exploring their roles and mechanisms of action. Before that, he spent four years as a post-doc at the Broad Institute under the joint supervision of Aviv Regev and Eric Lander.